Company intelligence / Profile preview

Bluefish Pharmaceuticals

Stockholm, Stockholm, Swedenbluefishpharma.com ↗

Ownership: Private
Employees: ~143
Development stage: Other

Overview

Bluefish Pharmaceuticals markets over 80 generic medicines across major therapeutic areas in Europe. The company focuses on affordable access to high-quality generics and continues to expand its portfolio through development and strategic partnerships. No proprietary clinical trial results are reported as the business model centers on established molecules.

Therapeutic areas: NeurologyInfectious DiseasesMen's HealthEndocrinologyOncologyCardiovascular
Modalities: Small molecule
Industry: Biotech

Partnerships

Tranzone Logistics for Middle East/Africa distribution

Beyond the preview

Go deeper on Bluefish Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bluefish Pharmaceuticals.

Explore the full profile